NCT03589079
Delineation of Novel Monogenic Disorders in the United Arab Emirates Population No drug interventions Not Available Not Available unknown_status NCT02769949
Pediatric Patients With Metabolic or Other Genetic Disorders No drug interventions Not Available Not Available recruiting NCT05737602
Promoting Stress Management and Resilience Among Individuals With Von Hippel- Lindau Disease No drug interventions supportive_care Not Available enrolling_by_invitation NCT01851447
Skeletal Muscle Biomarkers in People With Fragile Sarcolemmal Muscular Dystrophy No drug interventions Not Available Not Available active_not_recruiting NCT05212428
DNA Sequencing in Clinical Practice, Mayo Clinic Health Tapestry Study No drug interventions screening Not Available recruiting NCT00025870
Studies of Children With Metabolic and Other Genetic Disorders No drug interventions Not Available Not Available completed NCT01327924
Usability and Tolerability of the Norditropin NordiFlex® Injection Device in Children Never Previously Treated With Growth Hormone Not Available Not Available completed NCT01734486
Growth Response in Girls With Turner Syndrome treatment 4 completed NCT00358657
Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation Followed by Donor Bone Marrow Transplant and Cyclophosphamide, Mycophenolate Mofetil, Tacrolimus, and Sirolimus in Treating Patients With Primary Immunodeficiency Disorders or Noncancerous Inherited Disorders treatment 2 terminated NCT04743466
Evaluation of Association Between Testosterone Levels, Dementia, and Adverse Mental Health Outcomes No drug interventions Not Available Not Available recruiting NCT06362473
Lipid Transport Disorder Italian Genetic Record (LIPIGEN) No drug interventions Not Available Not Available recruiting NCT03435627
Post Marketing Surveillance on Long-term Use With Norditropin® (Short Stature Due to Noonan Syndrome) Not Available Not Available completed NCT01516229
Special Survey for Long Term Application Not Available Not Available completed NCT01435629
A Survey Collecting Data on Adult Height in Patients With Achondroplasia Treated With Somatropin Not Available Not Available completed NCT01529944
Genetic Testing of Noonan Subjects Previously Treated With Norditropin®. An Extension to Trial GHNOO-1658 treatment 3 completed NCT00705172
Retrospective Observational Study on Efficacy and Safety of Norditropin® in Children With Prader-Willi Syndrome Not Available Not Available completed NCT04681781
SLC13A5 Deficiency Natural History Study - Remote Only No drug interventions Not Available Not Available enrolling_by_invitation NCT03065114
Retrospective Study on Clinical Results of Preimplantation Genetic Screening at Different Embryo Stage No drug interventions Not Available Not Available completed NCT01500447
Inherited Reproductive Disorders No drug interventions Not Available Not Available recruiting NCT01927861
Investigating the Long-term Efficacy and Safety of Two Doses of NN-220 (Somatropin) in Short Stature Due to Noonan Syndrome treatment 3 completed NCT01604161
Non-interventional Study of Patients Using Norditropin® for Growth Hormone Deficiency or Turner Syndrome Not Available Not Available completed NCT00960128
Observational Prospective Study on Patients Treated With Norditropin® Not Available Not Available completed NCT01135537
Pharmacokinetics of Thymoglobulin in Paediatric Haematopoietic Stem-cell Transplants treatment 2 terminated NCT01518036
Use of Somatropin in Turner Syndrome treatment 3 completed NCT01710696
Induction of Puberty With 17-beta Estradiol in Girls With Turner Syndrome treatment 3 completed NCT01517048
Brain-Derived Neurotrophic Factor in Obesity and Brain Function No drug interventions Not Available Not Available completed NCT06144957
SLC13A5 Deficiency Natural History Study - United States Only No drug interventions Not Available Not Available recruiting NCT01563926
Evaluating Acceptance of New Liquid Somatropin Formulation in Children With Growth Hormone Deficiency treatment 3 completed NCT01245374
Norditropin NordiFlex® Device Compared to the Device Previously Used by Patients or Parents No drug interventions treatment 4 completed NCT03093220
Molecular Typing of Community-acquired Pneumonia Based on Multiple-omic Data Analysis No drug interventions Not Available Not Available unknown_status NCT01518062
Safety of Somatropin and Induction of Puberty With 17-beta-oestradiol in Girls With Turner Syndrome treatment 4 completed NCT01401244
Bioequivalence of Two Somatropin Products (Norditropin® Versus Genotropin®) in Healthy Adult Volunteers treatment 1 completed NCT01529840
Somatropin Effect on Linear Growth and Final Height in Subjects With Noonan Syndrome treatment 3 completed NCT01543867
Safety and Efficacy of Long-term Somatropin Treatment in Children Not Available Not Available completed NCT00262288
Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Patients With Hereditary Angioedema treatment 2 / 3 completed NCT00578435
Allogeneic Bone Marrow Transplantation for the Treatment of Genetic Disorders of Erythropoiesis No drug interventions treatment 2 completed NCT00214448
Reproducibility of the Array-Based Comparative Genomic Hybridization (aCGH) System Using Whole Blood Samples No drug interventions Not Available Not Available unknown_status NCT03911531
Whole Exome Sequencing and Whole Genome Sequencing for Nonimmune Fetal/Neonatal Hydrops No drug interventions Not Available Not Available recruiting NCT01902901
Clinical Implementation of Carrier Status Using Next Generation Sequencing No drug interventions screening Not Available completed NCT00705055
Face Anthropometric Pattern Recognition Technology for Computer Aided Diagnosis of Human Genetic Disorders. No drug interventions Not Available Not Available completed NCT00261053
Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Patients With Hereditary Angioedema treatment 2 completed NCT00851409
A Study of the Safety and Immunogenicity of Repeated rhC1INH Administration treatment 2 completed NCT01401257
Phase II, Randomized, Placebo-controlled Trial in Patients With Charcot-marie-tooth Disease Type 1A treatment 2 completed NCT00262301
Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Patients With Hereditary Angioedema treatment 3 completed